Prognostic Value of Soluble Urokinase-type Plasminogen Activator Receptor in Valvular Heart Disease
Clinical trial NCT04571372 · COMPLETED
Trial details
- NCT number
- NCT04571372
- Sponsor
- Yonsei University
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2020-08-14
- Primary completion
- 2025-12-13
- Enrollment
- 222
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.